Listen to the episode on your favorite platforms:
Audio roundup of selected biopharma industry content from Scrip over the business week ended December 19, 2025. This episode was produced with the help of AI text-to-voice and voice emulation tools.
This time – Regeneron caught between success and expiry; Q3’s top 10 drugs; Lilly’s Retatrutide Raises Weight-Loss Bar; Pfizer stands by vaccines investment; and Sanofi Upbeat Despite Tolebrutinib Tribulations.
Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-XA4W4OYCVRCSNHW5ZL7TUFJF2U/
Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
This time – Regeneron caught between success and expiry; Q3’s top 10 drugs; Lilly’s Retatrutide Raises Weight-Loss Bar; Pfizer stands by vaccines investment; and Sanofi Upbeat Despite Tolebrutinib Tribulations.
Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-XA4W4OYCVRCSNHW5ZL7TUFJF2U/
Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Smart linkhttps://pc.st/e/.JxW0LFtFK7
Official sitehttps://www.citeline.com/
Auto-openhttps://pc.st/e/.JxW0LFtFK7?a
Add podcast to the siteEmbed Podcast